| Amelogenesis imperfecta (AI) (amelogenesis – enamel formation;
imperfecta – imperfecta) is a relatively rare group of inherited
disorders characterized by abnormal enamel formation. The term amelogenesis
imperfecta is reserved for hereditary defects of enamel that are not
associated with defects in other parts of the body or other health
problems. The prevalence of these conditions has been studied in only
a few populations and has been reported to range from 1 in 700 to
1 in 15,000 [1-4].
The AI enamel defects are highly variable and include abnormalities
that are classified as hypoplastic (defect in amount of enamel),
hypomaturation (defect in final growth and maturation of enamel
crystallites), and hypocalcified (defect in initial crystallite
formation followed by defective growth) [5].
The enamel in both the hypomaturation and hypocalcified AI types
is not mineralized to the level of normal enamel and can be described
as hypomineralized. AI can be inherited as an x-linked, autosomal
recessive (AR), or autosomal dominant (AD) condition.
The diagnosis and classification of AI has traditionally been based
on the clinical presentation or phenotype and the inheritance pattern
[6]. Although multiple gene defects
responsible for causing AI have been identified since 1990, most
of the AI types do not have a known molecular basis. As the molecular
defects causing AI are identified, the need for a molecular based
nomenclature increases. The rapid identification of multiple mutations
in multiple genes has lead to the acceptance of standardized nomenclatures
for reporting AI associated mutations at the genomic, cDNA and protein
level [7]. The most widely accepted
classification system for delineating the AI types subdivides AI
into four main types based on the enamel defects and then further
divides them into14 distinct subtypes
based on clinical appearance (phenotype) and mode of inheritance
[6]. |